CD226 rs763361 Is associated with the susceptibility to type 1 diabetes and greater frequency of GAD65 autoantibody in a Brazilian cohort

Mediators of Inflammation

Volumn 2014, Issue , 2014, Pages

  Mattana, Teresa Cristina Colvara ^a   Santos, Aritania Sousa ^a   Fukui, Rosa Tsuneshiro ^a   Mainardi Novo, Debora Teixeira Oliveira ^a   Costa, Vinícius Silva ^a   Santos, Rosa Ferreira ^a   Matioli, Sergio Russo ^a   Rossi Da Silva, Maria Elizabeth ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; CD226 ANTIGEN; GLUCOSE; GLUTAMATE DECARBOXYLASE 65 ANTIBODY; HEMOGLOBIN A1C; LYMPHOCYTE ANTIGEN; RHEUMATOID FACTOR; SMOOTH MUSCLE ANTIBODY; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; AUTOANTIBODY; GLUTAMATE DECARBOXYLASE; GLUTAMATE DECARBOXYLASE 2; T LYMPHOCYTE ANTIGEN;

ADULT; ALLELE; ARTICLE; BRAZIL; CONTROLLED STUDY; DISEASE PREDISPOSITION; EXON; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; GLUCOSE BLOOD LEVEL; HAPLOTYPE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INTRON; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; 3' UNTRANSLATED REGION; ADOLESCENT; BLOOD; CASE CONTROL STUDY; CHEMISTRY; CHILD; COHORT ANALYSIS; GENETIC PREDISPOSITION; GENETICS; POLYMERASE CHAIN REACTION; SINGLE NUCLEOTIDE POLYMORPHISM; YOUNG ADULT;

3' UNTRANSLATED REGIONS; ADOLESCENT; ADULT; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; AUTOANTIBODIES; BRAZIL; C-PEPTIDE; CASE-CONTROL STUDIES; CHILD; COHORT STUDIES; DIABETES MELLITUS, TYPE 1; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GLUTAMATE DECARBOXYLASE; HUMANS; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; YOUNG ADULT;

EID: 84901787394     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2014/694948     Document Type: Article

References (27)

1. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 2011 34 supplement 1 S1 S2
2. Eisenbarth G. S., Jeffrey J., The natural history of type 1A diabetes. Arquivos Brasileiros de Endocrinologia e Metabologia 2008 52 2 146 153 2-s2.0-43249094488 10.1590/S0004-27302008000200002
3. Nokoff N., Rewers M., Pathogenesis of type 1 diabetes: lessons from natural history studies of high-risk individuals. Annals of the New York Academy of Sciences 2013 1281 1 1 15 10.1111/nyas.12021
4. Barrett J. C., Clayton D. G., Concannon P., Akolkar B., Cooper J. D., Erlich H. A., Julier C., Morahan G., Nerup J., Nierras C., Plagnol V., Pociot F., Schuilenburg H., Smyth D. J., Stevens H., Todd J. A., Walker N. M., Rich S. S., Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nature Genetics 2009 41 6 703 707 2-s2.0-67349199566 10.1038/ng.381
5. Alves L. I., Davini E., Correia M. R., Fukui R. T., Santos R. F., Cunha M. R., Rocha D. M., Volpini W. M. G., Silva M. E. R., Autoantibodies and high-risk HLA susceptibility markers in first-degree relatives of Brazilian patients with type 1 diabetes mellitus: a progression to disease based study. Journal of Clinical Immunology 2012 32 4 778 785 2-s2.0-84857694507 10.1007/s10875-012-9673-4
6. Mainardi-Novo D. T. O., Santos A. S., Fukui R. T., Gamberini M., Correia M. R. S., Ruiz M. O., Mangueira C. L., Matioli S. R., Vasconcelos D. M., Silva M. E., The PTPN22 1858T allele but not variants in the proximal promoter region of IL-21 gene is associated with the susceptibility to type 1 diabetes and the presence of autoantibodies in a Brazilian cohort. Clinical and Experimental Immunology 2013 172 1 16 22
7. Da Silva M. E. R., Mory D., Davini E., Genetic and humoral autoimmunity markers of type 1 diabetes: from theory to practice. Arquivos Brasileiros de Endocrinologia e Metabologia 2008 52 2 166 180 2-s2.0-43249110894 10.1590/S0004-27302008000200004
8. Lins T. C., Vieira R. G., Abreu B. S., Grattapaglia D., Pereira R. W., Genetic composition of Brazilian population samples based on a set of twenty eight ancestry informative SNPs. The American Journal of Human Biology 2010 22 2 187 192 2-s2.0-77249160660 10.1002/ajhb.20976
9. Negrato C. A., Dias J. P. L., Teixeira M. F., Dias A., Salgado M. H., Lauris J. R., Montenegro R. M. Jr., Gomes M. B., Jovanovic L., Temporal trends in incidence of type 1 diabetes between 1986 and 2006 in Brazil. Journal of Endocrinological Investigation 2010 33 6 373 377 2-s2.0-77955342552 10.3275/6439
10. Todd J. A., Walker N. M., Cooper J. D., Smyth D. J., Downes K., Plagnol V., Bailey R., Nejentsev S., Field S. F., Payne F., Lowe C. E., Szeszko J. S., Hafler J. P., Zeitels L., Yang J. H. M., Vella A., Nutland S., Stevens H. E., Schuilenburg H., Coleman G., Maisuria M., Meadows W., Smink L. J., Healy B., Burren O. S., Lam A. A. C., Ovington N. R., Allen J., Adlem E., Leung H., Wallace C., Howson J. M. M., Guja C., Ionescu-Tîrgovişte C., Simmonds M. J., Heward J. M., Gough S. C. L., Dunger D. B., Wicker L. S., Clayton D. G., Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes. Nature Genetics 2007 39 7 857 864 2-s2.0-34347341846 10.1038/ng2068 (Pubitemid 47018195)
11. Shibuya A., Tahara-Hanaoka S., Shibuya K., DNAM-1 (CD226): a two-sword fencer for innate and adaptive immunity. Current Medicinal Chemistry: Anti-Inflammatory and Anti-Allergy Agents 2005 4 1 53 58 2-s2.0-12744254932 10.2174/1568014053005390
12. Tahara-Hanaoka S., Shibuya K., Onoda Y., Zhang H., Yamazaki S., Miyamoto A., Honda S., Lanier L. L., Shibuya A., Functional characterization of DNAM-1 (CD226) interaction with its ligands PVR (CD155) and nectin-2 (PRR-2/CD112). International Immunology 2004 16 4 533 538 2-s2.0-1842865730 10.1093/intimm/dxh059 (Pubitemid 38489427)
13. Shibuya A., Campbell D., Hannum C., Yssel H., Franz-Bacon K., McClanashan T., Kitamura T., Nicholl J., Sutherland G. R., Lanier L. L., Phillips J. H., DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity 1996 4 6 573 581 2-s2.0-15844375309 10.1016/S1074-7613(00) 70060-4 (Pubitemid 26233311)
14. Lozano E., Joller N., Cao Y., Kuchroo V. K., Hafler D. A., The CD226/CD155 interaction regulates the proinflammatory (Th1/Th17)/anti- inflammatory (Th2) balance in humans. The Journal of Immunology 2013 191 7 3673 3680 10.4049/jimmunol.1300945
15. Lozano E., Dominguez-Villar M., Kuchroo V., Hafler D. A., The TIGIT/CD226 axis regulates human T cell function. Journal of Immunology 2012 188 8 3869 3875 2-s2.0-84860329359 10.4049/jimmunol.1103627
16. Shibuya K., Shirakawa J., Kameyama T., Honda S., Tahara-Hanaoka S., Miyamoto A., Onodera M., Sumida T., Nakauchi H., Miyoshi H., Shibuya A., CD226 (DNAM-1) is involved in lymphocyte function-associated antigen 1 costimulatory signal for naive T cell differentiation and proliferation. Journal of Experimental Medicine 2003 198 12 1829 1839 2-s2.0-9144273834 10.1084/jem.20030958 (Pubitemid 38032116)
17. Shirakawa J., Shibuya K., Shibuya A., Requirement of the serine at residue 329 for lipid raft recruitment of DNAM-1 (CD226). International Immunology 2005 17 3 217 223 2-s2.0-14944364789 10.1093/intimm/dxh199 (Pubitemid 40372644)
18. Hafler J. P., Maier L. M., Cooper J. D., Plagnol V., Hinks A., Simmonds M. J., Stevens H. E., Walker N. M., Healy B., Howson J. M. M., Maisuria M., Duley S., Coleman G., Gough S. C. L., Worthington J., Kuchroo V. K., Wicker L. S., Todd J. A., CD226 Gly307Ser association with multiple autoimmune diseases. Genes and Immunity 2009 10 1 5 10 2-s2.0-59149098926 10.1038/gene.2008.82
19. Maiti A. K., Kim-Howard X., Viswanathan P., Guillén L., Qian X., Rojas-Villarraga A., Sun C., Cañas C., Tobón G. J., Matsuda K., Shen N., Cherñavsky A. C., Anaya J., Nath S. K., Non-synonymous variant (Gly307Ser) in CD226 is associated with susceptibility to multiple autoimmune diseases. Rheumatology 2010 49 7 1239 1244 2-s2.0-77954208061 10.1093/rheumatology/kep470
20. Douroudis K., Kingo K., Silm H., Reimann E., Traks T., Vasar E., Kõks S., The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. Journal of Dermatological Science 2010 58 2 160 161 2-s2.0-77952241926 10.1016/j.jdermsci.2010.03.015
21. Wieczorek S., Hoffjan S., Chan A., Rey L., Harper L., Fricke H., Holle J. U., Gross W. L., Epplen J. T., Lamprecht P., Novel association of the CD226 (DNAM-1) Gly307Ser polymorphism in Wegener's granulomatosis and confirmation for multiple sclerosis in German patients. Genes and Immunity 2009 10 6 591 595 2-s2.0-69949115526 10.1038/gene.2009.44
22. Löfgren S. E., Delgado-Vega A. M., Gallant C. J., Sánchez E., Frostegård J., Truedsson L., de Ramón Garrido E., Sabio J. M., González-Escribano M. F., Pons-Estel B. A., D'Alfonso S., Witte T., Lauwerys B. R., Endreffy E., Kovács L., Vasconcelos C., da Silva B. M., Martín J., Alarcón-Riquelme M. E., Kozyrev S. V., A 3′-untranslated region variant is associated with impaired expression of CD226 in T and natural killer T cells and is associated with susceptibility to systemic lupus erythematosus. Arthritis and Rheumatology 2010 62 11 3404 3414 10.1002/art.27677
23. Douroudis K., Nemvalts V., Rajasalu T., Kisand K., Uibo R., The CD226 gene in susceptibility of type 1 diabetes. Tissue Antigens 2009 74 5 417 419 2-s2.0-70350068424 10.1111/j.1399-0039.2009.01320.x
24. Wallace C., Rotival M., Cooper J. D., Rice C. M., Yang J. H., McNeill M., Smyth D. J., Niblett D., Cambien; Cardiogenics Consortium F., Tiret L., Todd J. A., Clayton D. G., Blankenberg S., Statistical colocalization of monocyte gene expression and genetic risk variants for type 1 diabetes. Human Molecular Genetics 2012 21 12 2815 2824 10.1093/hmg/dds098
25. Cutolo M., Sulli A., Straub R. H., Estrogen metabolism and autoimmunity. Autoimmunity Reviews 2012 11 6-7 A460 A464 2-s2.0-84858438060 10.1016/j.autrev.2011.11.014
26. Nussinovitch U., Shoenfeld Y., The role of gender and organ specific autoimmunity. Autoimmunity Reviews 2012 11 6-7 A377 A385 2-s2.0-84858450790 10.1016/j.autrev.2011.11.001
27. Cucca F., Goy J. V., Kawaguchi Y., Esposito L., Merriman M. E., Wilson A. J., Cordell H. J., Bain S. C., Todd J. A., A male-female bias in type 1 diabetes and linkage to chromosome Xp in MHC HLA-DR3-positive patients. Nature Genetics 1998 19 3 301 302 2-s2.0-0031833918 10.1038/995 (Pubitemid 28309349)